MedTrace Logo

Effects of H1-Antagonist on Cognition

NCT00846950 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 18

Last updated 2009-02-19

No results posted yet for this study

Summary

The purpose of this study is to determine whether histamine is involved in memory and specific processes in human cognition.

Conditions

  • Cognition

Interventions

DRUG

dexchlorpheniramine, lorazepam

Sponsors & Collaborators

  • Maastricht University Medical Center

    lead OTHER

Principal Investigators

  • Annemiek Vermeeren, Ph.D. · Maastricht University hospital

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-12-31
Primary Completion
2007-05-31
Completion
2007-05-31

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00846950 on ClinicalTrials.gov